Workflow
Belite Bio(BLTE) - 2024 Q1 - Earnings Call Transcript
BLTEBelite Bio(BLTE)2024-05-15 00:11

Hao-Yuan Chuang On G&A expenses in Q1 2024, G&A expenses was $1.6 million compared to $1.2 million in Q1 2023. The increase was primarily due to increasing share-based compensation granted in the third quarter of 2023. In addition, we raised additional $25 million from our registered rent offering in April. We expect cash runway beyond 2026. Thank you. Back to you, Tom. Thanks, Hao. I would like to conclude with the key milestones to expect for this year. We are still making good progress in the Phase 3 in ...